What is The Procter & Gamble's latest dividend and current dividend yield?

Did The Procter & Gamble beat or miss consensus estimates last quarter?

What were the key takeaways from The Procter & Gamble's earnings call?

What is the market's earnings forecast for The Procter & Gamble next quarter?

What factors drove the changes in The Procter & Gamble's revenue and profit?

What is The Procter & Gamble's gross profit margin?

What is the revenue and EPS growth rate for The Procter & Gamble year over year?

What does The Procter & Gamble do and what are its main business segments?

- **Global Growth Momentum**: 3% organic growth outside U.S., led by Latin America (8%), China (3%), and Europe (1%).
- **Innovation Success**: Pampers Prestige (China) and Downy Intense (Mexico) drive double-digit growth.
- **U.S. Recovery Plan**: New products (Tide evo, Olay) and sharper execution to offset base-period inventory headwinds.
- **Financial Resilience**: Core EPS $1.88, 88% free cash flow productivity, and FY26 guidance for 0-4% growth across metrics.
- **Strategic Focus**: Reinventing P&G through data, AI, and consumer-centric innovation to create superior value.

**【CEO Summary Section】**
- Organic sales growth of 3% outside the U.S., driven by Latin America (8%), Greater China (3%), and Europe (1%).
- Key innovations: Pampers Prestige in China (double-digit growth), Downy Intense in Mexico (double-digit growth), and Tide Boost in the U.S.
- Focus on consumer-centric innovation, sharper execution, and brand communication to accelerate U.S. recovery.
- Long-term strategy: Reinvent P&G by leveraging data, AI, and supply chain to create superior consumer propositions.

**【CFO Financial Commentary】**
- Q2 organic sales flat YoY, with Family Care down 10% due to base-period inventory impacts.
- Core EPS $1.88, in line with prior year; adjusted free cash flow productivity 88%.
- FY26 guidance: Organic sales growth 0-4%, core EPS 0-4%, and free cash flow productivity 85-90%.
- FY26 outlook includes $500M pre-tax tariffs and $250M after-tax tax headwinds.
- Strong reinvestment of productivity (270bps) in innovation and demand creation.

**【Q&A Highlights】**
- **Near-term confidence**: Strong execution in Latin America, Europe, and China; U.S. recovery driven by new innovations (e.g., Tide evo, Olay launches).
- **Long-term reinvention**: Building data platforms, AI tools, and supply chain 3.0 for consumer-centric growth.
- **U.S. strategy**: Focus on value through product performance (e.g., Tide Boost), media efficiency, and in-store trial.
- **Margins**: Productivity gains (270bps) reinvested in growth; FY26 EPS guidance reflects cautious macro assumptions.
- **Share recovery**: Targeting share growth in U.S. and globally through superior propositions and execution.

The Procter & Gamble Company (PG) Q2 2026 Earnings Call Transcript

- **Topline Growth**: 2% organic sales driven by Latin America (+7%) and China (+5%), despite U.S. category deceleration.
- **Profitability**: Core EPS +3% to $1.99, with 102% free cash flow productivity and $3.8B shareholder returns.
- **Innovation Edge**: Tide evo test-market success, SK-II premium body wash +80% online, and Baby Dry mid-tier expansion.
- **Restructuring Impact**: 7,000 job cuts to enable $1.5B savings; China restructured go-to-market model driving Baby Care +20%.
- **Risks & Tailwinds**: Commodity headwinds reduced to $100M, but Q2 2026 softer due to prior year port strike distortions.

**【CFO Overview】**
- Q1 2026 organic sales growth of 2%, driven by broad-based category performance (8/10 categories grew) and regional strength in Latin America (+7%) and Greater China (+5%).
- Core EPS of $1.99, up 3% YoY, with strong free cash flow productivity (102%) and $3.8B returned to shareholders (dividends + buybacks).
- Global market share down 30bps, but 24/50 category-country combinations held or gained share.

**【Financial Highlights】**
- Core gross margin down 50bps, offset by 230bps productivity gains.
- Adjusted free cash flow of $1.8B, with $10B+ dividends and $5B+ buybacks planned for FY26.
- Commodity headwind reduced to $100M (from $300M), tariff tailwind of $300M, and $500M restructuring costs.

**【Strategy & Innovation】**
- **Product Innovation**: Tide evo (recyclable, no plastic) launched in test markets with strong retailer demand; SK-II premium body wash (+80% online); Pampers Baby Dry mid-tier innovation.
- **Restructuring**: 7,000 non-manufacturing job cuts (15% workforce reduction) to enable $1.5B+ COGS savings; portfolio rationalization (e.g., Pakistan import model, India laundry bar exit).
- **Market Focus**: China restructured go-to-market model, driving 20% Baby Care growth; Latin America Personal HealthCare +15%.

**【Q&A Highlights】**
- **North America Dynamics**: Fabric Care and Baby Care facing competitive promotions; response via innovation (Tide boosted formula, Luvs Platinum value tier).
- **China Recovery**: 5% organic growth driven by SK-II (+12%), Olay premium body wash (+80% online), and Baby Care (+20%).
- **Tariff Impact**: Exemptions for natural ingredients (e.g., psyllium) reduced headwinds; Q2 2026 softer due to prior year port strike distortions.
- **AI & Commerce**: Partnering with OpenAI/Walmart to leverage generative AI for consumer insights and basket optimization.


The Procter & Gamble Company (PG) Q1 2026 Earnings Call Transcript

- **Leadership Transition**: Shailesh Jejurikar to lead with restructuring to streamline operations and drive growth.
- **Financial Performance**: FY25 core EPS $6.83, FY26 guidance 0-4% organic growth, facing $1B tariff headwind.
- **Innovation Success**: Swiffer PowerMop, Tide evo, SK-II LXP deliver category-leading growth.
- **Tariff Mitigation**: Pricing and productivity to offset costs, but consumer confidence critical.
- **China Recovery**: Sequential improvement with innovation-driven Baby Care and SK-II growth.

**【CEO Opening Remarks】**
- Jon Moeller announced his transition to Executive Chairman, with Shailesh Jejurikar becoming CEO, emphasizing a planned leadership succession.
- Highlighted P&G's strategy of balanced top and bottom line growth, focusing on superior product innovation and market share gains.
- Discussed the 2-year restructuring program to streamline portfolio, supply chain, and organization, targeting 7,000 non-manufacturing job reductions.

**【CFO Financial Commentary】**
- FY25 organic sales grew 2%, with North America and Latin America leading at 2% and 4% respectively.
- Core EPS of $6.83, up 4%, driven by productivity improvements and cost control.
- FY26 guidance: organic sales 0-4% growth, core EPS $6.83-$7.09, with $200M tariff headwind and $300M FX tailwind.
- Adjusted free cash flow productivity expected at 85-90%, supporting $15B cash return.

**【CEO Strategy Discussion】**
- Emphasized 5 vectors of innovation: product, package, brand communication, retail execution, and value.
- Examples of successful innovations: Swiffer PowerMop (40% category growth), Tide evo (test market success), SK-II LXP (super-premium segment growth).
- Restructuring aims to create $1.5B gross savings, enabling reinvestment in growth and margin expansion.

**【Q&A Highlights】**
- **Tariff Impact**: FY26 expects $1B tariff headwind, with 50% from China-US trade. Pricing and productivity will mitigate, but consumer confidence is key.
- **U.S. Market**: Inventory destocking in Focus Markets, but online and club channels growing. Consumer trade-down pressure countered by innovation.
- **China Recovery**: Q4 organic sales +2%, driven by 618 event. Innovation in Baby Care and SK-II driving share gains.
- **Restructuring Savings**: $1B pre-tax savings to begin in FY26H2, supporting EPS growth despite headwinds.
- **Consumer Trends**: Slow category growth due to macro uncertainty, but P&G's daily use portfolio resilient.


The Procter & Gamble Company (PG) Q4 2025 Earnings Call Transcript

- **Q3 Growth Resilience**: 1% organic sales vs flat consensus, driven by SK-II (+11%), Oral-B (+50bps share), and broad category hold (7/10 up).
- **FY25 Guidance**: +2% sales, +2-4% EPS. Q4 0.5-4.5% growth range reflects consumer uncertainty.
- **Tariff Mitigation Plan**: $1B-$1.5B impact offset by productivity ($200M+ savings), sourcing, and pricing. 3-year glide path to balance top/bottom line.
- **Innovation Edge**: Tide EVO test market success (+category growth vs premium price), SK-II LXP super-premium growth, Oral-B I-10 premiumization.
- **Shareholder Returns**: $16B-$17B total returns (dividends + buybacks), 90%+ free cash flow productivity.


**【CEO Summary Section】**
- Organic sales grew 1% Q3, with 7 of 10 categories holding or growing. North America and Europe saw modest growth despite consumer volatility. SK-II in China grew double digits on innovation. Global market share held well, with private label share declining in key regions.
- Guidance for FY25: Organic sales +2%, core EPS $6.72-$6.82 (+2-4% vs prior year). Q4 organic growth expected 0.5-4.5%.
- Strategy focus: Maintain innovation pipeline, productivity investments, and long-term category growth despite near-term macro challenges.

**【CFO Financial Commentary】**
- Core EPS $1.54 (+1% YoY), core operating margin +100bps to 16.3%. Adjusted free cash flow productivity 75%, returning $3.8B to shareholders (dividends + buybacks).
- FY25 outlook: Commodity cost headwind $200M, FX headwind $200M, tariffs $100M-$160M Q4. Free cash flow productivity 90%, $16B-$17B total returns (dividends + buybacks).
- Tariff impact FY25: $1B-$1.5B pre-tax, primarily from China imports and U.S. exports to Canada.

**【Strategy & Innovation Highlights】**
- Innovation pipeline strong: Tide EVO, Oral-B I-10, Oxy Boost Fabric Care, SK-II LXP. Test market results exceed expectations (EVO +category growth vs premium pricing).
- Productivity initiatives: 280bps cost savings vs plan, including compensation adjustments. 3-year productivity plan to offset tariffs and inflation.
- Portfolio optimization: Focus on U.S. dollar-based returns in daily use categories. France law implementation annualized, easier comps ahead.

**【Q&A Key Themes】**
- **Consumer Behavior**: U.S. and Europe consumption down 2pts YoY, but P&G share held due to brand superiority. Shift to online/big box/club channels, not trade-down.
- **Tariff Mitigation**: Productivity ($200M+ savings), sourcing flexibility, selective pricing. 12-18mo timeline for full mitigation.
- **China Recovery**: SK-II +11% on LXP innovation, but overall market soft. Pampers, Oral-B, Fabric Care showing progress.
- **Supply Chain Resilience**: 70%+ production near key markets. No plans to shift long-term sourcing due to tariffs.


The Procter & Gamble Company (PG)-24 Apr 25-2025 Q3 Earnings call transcript

- **Topline Resilience**: Q2 organic +3% (North America +4%), FY25 guidance 3-5% despite $0.20 EPS FX/commodity headwinds.
- **China Turnaround**: Q2 down 3% vs. Q1 15% decline, SK-II +5%, core brands gaining share via digital channel expansion.
- **Innovation Edge**: 260bps productivity gains, 3-year cost savings plans, 19/20 quarters with pricing contribution.
- **Cash Return**: $4.9B returned Q2, FY25 target $16-17B ($10B dividends, $6-7B buybacks).

**【CFO Second Quarter Overview】**
- Organic sales grew 3% driven by 2% volume and 1% mix, with North America up 4% on 4% volume growth. 
- Core EPS of $1.88 (+2% YoY) included $0.02 incremental costs from a TMS outage. 
- Adjusted free cash flow productivity was 84%, with $4.9B returned to shareholders ($2.4B dividends, $2.5B buybacks).

**【CEO Strategic Update】**
- 26 consecutive quarters of ≥2% organic sales growth (5.5% avg), 8.5 years of ≥2% core EPS growth (8% avg). 
- Key innovations: Charmin smooth tear (+share), Swiffer PowerMop (+40% brand growth), Tide evo test market success. 
- Productivity improvements of 260bps vs. prior year, 3-year cost savings plans in development.

**【CFO Full Year Guidance】**
- Organic sales: 3-5% growth (3-4% market growth + modest outperformance). 
- Core EPS: $6.91-7.05 (+5-7% vs. $6.59 FY24). 
- Headwinds: $0.08 from commodities, $0.12 from FX, $0.10-12 from lower nonop income/tax. 
- Free cash flow productivity target: 90% ($16-17B total returns).

**【Q&A Key Takeaways】**
- **China Recovery**: Q2 organic down 3% vs. Q1 15% decline, SK-II +5%, core brands gaining share via Douyin investment. 
- **FX Risk**: $0.12 EPS headwind from weaker EUR/GBP, hedging 70% of FY25 exposure. 
- **Innovation Momentum**: 19/20 quarters with pricing contribution, 54/57 quarters with neutral/positive pricing impact.

Actual															1.17	1.16	1.63	1.64	1.26	1.13	1.61	1.66	1.33	1.21	1.57	1.59	1.37	1.37	1.83	1.84	1.52	1.4	1.93	1.88	1.54	1.48	1.99	1.88
Forecast															1.132	1.0112	1.4178	1.5104	1.1876	1.0845	1.5899	1.652	1.2917	1.2235	1.5518	1.587	1.323	1.3232	1.7194	1.6974	1.4169	1.3739	1.8986	1.8583	1.52	1.4215	1.8971	1.8742	1.568
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+3.36%	+14.72%	+14.97%	+8.58%	+6.10%	+4.20%	+1.26%	+0.48%	+2.97%	-1.10%	+1.17%	+0.19%	+3.55%	+3.54%	+6.43%	+8.40%	+7.28%	+1.90%	+1.65%	+1.17%	+1.32%	+4.12%	+4.90%	+0.31%	0.00%

Actual	--	--	--	--	--	--	--	--	--	--	--	--	--	--	17.21B	17.70B	19.32B	19.75B	18.11B	18.95B	20.34B	20.95B	19.38B	19.52B	20.61B	20.77B	20.10B	20.55B	21.87B	21.44B	20.20B	20.53B	21.74B	21.88B	19.78B	20.89B	22.39B	22.21B	--
Forecast	--	--	--	--	--	--	--	--	--	--	--	--	--	--	17.31B	16.95B	18.38B	19.27B	17.96B	18.37B	19.83B	20.33B	18.71B	19.40B	20.37B	20.75B	19.28B	20.01B	21.58B	21.48B	20.43B	20.72B	21.99B	21.58B	20.15B	20.84B	22.18B	22.36B	20.59B
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.54%	+4.44%	+5.13%	+2.47%	+0.82%	+3.12%	+2.58%	+3.04%	+3.61%	+0.57%	+1.21%	+0.13%	+4.25%	+2.71%	+1.35%	-0.16%	-1.17%	-0.93%	-1.13%	+1.41%	-1.88%	+0.23%	+0.92%	-0.68%	0.00%

PG

PG fundamentals

PG Q3 2026 Earnings Preview

Earnings Call

You can ask Aime

PG

PG fundamentals

PG Q3 2026 Earnings Preview

Earnings Call

PG Earnings Call Summary for Q3/2026Upcoming Mar 26, 2026

PG Earnings Call Summary for Q2/20268:30 AM on Jan 22, 2026

PG Earnings Call Summary for Q1/20268:30 AM on Oct 24, 2025

PG Earnings Call Summary for Q4/20258:30 AM on Jul 29, 2025

PG Earnings Call Summary for Q3/20258:30 AM on Apr 24, 2025

You can ask Aime